Do you want to read an article? Please log in or register.
Oral administration of a lecithin-based delivery form of boswellic acids (Casperome®) for the prevention of symptoms of irritable bowel syndrome: a randomized clinical study
Irritable Bowel Syndrome (IBS) and Chronic Constipation